X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
index medicus (50) 50
oncology (46) 46
male (41) 41
middle aged (38) 38
female (35) 35
adult (29) 29
aged (29) 29
chemotherapy (22) 22
cancer (18) 18
care and treatment (14) 14
lung neoplasms - pathology (14) 14
survival (14) 14
neoplasm staging (13) 13
aged, 80 and over (12) 12
lung cancer (12) 12
lung neoplasms - drug therapy (12) 12
metastasis (12) 12
treatment outcome (12) 12
analysis (11) 11
antineoplastic agents - therapeutic use (11) 11
carcinoma, non-small-cell lung - drug therapy (11) 11
carcinoma, non-small-cell lung - pathology (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
survival analysis (10) 10
tumors (10) 10
cisplatin (9) 9
lung neoplasms - diagnosis (9) 9
medicine & public health (9) 9
prognosis (9) 9
research (9) 9
therapy (9) 9
cisplatin - administration & dosage (8) 8
hematology, oncology and palliative medicine (8) 8
respiratory system (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
carcinoma, non-small-cell lung - therapy (7) 7
chemoradiotherapy (7) 7
lung cancer, non-small cell (7) 7
lung neoplasms - therapy (7) 7
patients (7) 7
prospective studies (7) 7
squamous cell carcinoma of head and neck (7) 7
surgery (7) 7
young adult (7) 7
biomarker (6) 6
biomarkers (6) 6
cancer research (6) 6
carcinoma, non-small-cell lung - diagnosis (6) 6
carcinoma, squamous cell - drug therapy (6) 6
combined modality therapy (6) 6
drug therapy (6) 6
erlotinib (6) 6
germany (6) 6
head and neck neoplasms - drug therapy (6) 6
kaplan-meier estimate (6) 6
mutation (6) 6
neoplasms (6) 6
nsclc (6) 6
pharmacology & pharmacy (6) 6
phase-iii (6) 6
retrospective studies (6) 6
trial (6) 6
adolescent (5) 5
afatinib (5) 5
article (5) 5
biopsy (5) 5
diagnosis (5) 5
dose-response relationship, drug (5) 5
fluorodeoxyglucose f18 (5) 5
gemcitabine (5) 5
internal medicine (5) 5
lung neoplasms - mortality (5) 5
medical prognosis (5) 5
medical research (5) 5
metastases (5) 5
oncology, experimental (5) 5
pancreatic neoplasms - drug therapy (5) 5
quinazolines - administration & dosage (5) 5
quinazolines - adverse effects (5) 5
research article (5) 5
resection (5) 5
solid tumors (5) 5
urology (5) 5
urology & nephrology (5) 5
adenocarcinoma (4) 4
antineoplastic agents (4) 4
breast-cancer (4) 4
carcinoma (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
carcinoma, non-small-cell lung - mortality (4) 4
carcinoma, renal cell (4) 4
carcinoma, renal cell - drug therapy (4) 4
cell lung-cancer (4) 4
chemoradiation (4) 4
combination (4) 4
deoxycytidine - administration & dosage (4) 4
deoxycytidine - analogs & derivatives (4) 4
disease-free survival (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 19, pp. 1803 - 1813
Journal Article
European Urology, ISSN 0302-2838, 04/2018, Volume 73, Issue 4, pp. e116 - e118
The publisher regrets that an error occurred during the preparation of Figure 1A for final publication. The position of some of the point estimates and the... 
Journal Article
Gut, ISSN 0017-5749, 05/2013, Volume 62, Issue 5, pp. 751 - 759
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e85350
Background: Oncogenic mutations are powerful predictive biomarkers for molecularly targeted cancer therapies. For mutation detection patients have to undergo... 
BREAST-CANCER | GROWTH-FACTOR RECEPTOR | GEFITINIB | RARE MUTATIONS | MULTIDISCIPLINARY SCIENCES | PROGNOSTIC-SIGNIFICANCE | RESISTANT PROSTATE-CANCER | METASTATIC COLORECTAL-CANCER | EGFR | PROGRESSION | ERLOTINIB | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Neoplastic Cells, Circulating - pathology | Humans | Middle Aged | Real-Time Polymerase Chain Reaction - methods | Neoplastic Cells, Circulating - metabolism | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Neoplasm Recurrence, Local - pathology | Sensitivity and Specificity | Adult | Female | Single-Cell Analysis | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Nucleic Acid Denaturation | Neoplasm Recurrence, Local - prevention & control | Carcinoma, Non-Small-Cell Lung - genetics | Neoplasm Recurrence, Local - diagnosis | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Care and treatment | Analysis | Genes | Development and progression | Genetic aspects | Metastasis | Lung cancer, Non-small cell | Health aspects | Methods | Cancer | Genomics | Lung cancer | Medical services | Oncology | Melting curve | Hybridization | Kinases | Assaying | Blood | Consortia | Peripheral blood | Bioindicators | Pretreatment | Growth factors | Deoxyribonucleic acid--DNA | Medical research | Melting | Epidermal growth factor receptors | Tumor cells | Invasiveness | Blood cells | Non-small cell lung carcinoma | Patients | Polymerase chain reaction | Pathology | Mutagenesis | Lungs | Biopsy | Biomarkers | Mutation | Genetic testing | Deoxyribonucleic acid | DNA
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 6/2014, Volume 73, Issue 6, pp. 1227 - 1239
Journal Article
Future Oncology, ISSN 1479-6694, 01/2014, Volume 10, Issue 1, pp. 21 - 40
Aberrant signaling of the ErbB family of receptors plays an integral role in the tumorigenesis of many cancer types, including head and neck squamous cell... 
afatinib | breast cancer | HER2 | EGFR | ErbB family | head and neck squamous cell carcinoma | BIBW 2992 | ACQUIRED-RESISTANCE | OPEN-LABEL | MONOCLONAL-ANTIBODY | HUMAN-PAPILLOMAVIRUS | GROWTH-FACTOR RECEPTOR | LUNG-CANCER | DOSE-ESCALATION | PHASE-II TRIAL | ONCOLOGY | TYROSINE KINASE INHIBITOR
Journal Article
BMC Cancer, ISSN 1471-2407, 08/2014, Volume 14, Issue 1, p. 624
Journal Article
PLoS ONE, 01/2014, Volume 9, Issue 1
Background Oncogenic mutations are powerful predictive biomarkers for molecularly targeted cancer therapies. For mutation detection patients have to undergo... 
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2013, Volume 8, Issue 1, pp. 19 - 30
Journal Article